Otitis in a cat associated with Corynebacterium provencense

Abstract

Background

The role of corynebacteria in canine and feline otitis has not been investigated in detail; however, members of this genus are increasingly recognized as pathogens of otitis in both human and veterinary medicine.

Case presentation

Here we report the first case of feline otitis associated with the recently described species Corynebacterium provencense. A seven-month old cat presented with a head tilt and ataxia was diagnosed with peripheral vestibular syndrome associated with an otitis media/interna. This took place 6 weeks after resection of a polyp, having initially shown a full recovery with topical ofloxacin and glucocorticoid treatment. Bacteriology of an ear swab yielded a pure culture of corynebacteria, which could not be identified at the species level using routine methods. However, the 16S rRNA gene sequence was 100% identical to the recently published novel corynebacterium species, Corynebacterium provencense. Whole genome sequencing of the cat isolate and calculation of average nucleotide identity (99.1%) confirmed this finding. The cat isolate was found to contain additional presumptive iron acquisition genes that are likely to encode virulence factors. Furthermore, the strain tested resistant to clindamycin, penicillin and ciprofloxacin. The cat was subsequently treated with chloramphenicol, which lead to clinical improvement.

Conclusion

Corynebacteria from otitis cases are not routinely identified at the species level and not tested for antimicrobial susceptibility in veterinary laboratories, as they are not considered major pathogens. This may lead to underreporting of this genus or animals being treated with inappropriate antimicrobials since corynebacteria are often resistant to multiple drugs.

Electronic supplementary material

The online version of this article (10.1186/s12917-018-1526-9) contains supplementary material, which is available to authorized users.

Background

The genus Corynebacterium consists of 128 species [1], with a large number pathogenic to humans and animals [2]. The main animal pathogens include C. pseudotuberculosis, C. kutscheri, the C. renale group, C. bovis and C. ulcerans while C. diphtheriae is considered the main human pathogen [3]. Many other Corynebacterium spp. have been isolated from opportunistic infection sites in humans and animals, sometimes also with a zoonotic origin [2]. Besides the diphtheria toxin, which is the major virulence factor in C. diphtheriae (also found in other species like C. ulcerans) [4], and phospholipase D, a virulence factor of C. pseudotuberculosis and C. ulcerans [5], relatively little is known about virulence traits in the genus Corynebacterium.

Recently human and veterinary diagnostic laboratories have begun to investigate the role of Corynebacterium spp. as causative agents for otitis with a study [6] finding Corynebacterium spp. to be present in 33% of human patients with otologic infections. These cases were often resistant to fluoroquinolones, an antibiotic frequently used as a first-line in treatment [6]. In dogs, Corynebacterium spp. are also increasingly recognized as otitis-associated pathogens, however, in most cases they are isolated together with other pathogens [7, 8]. There are even fewer publications describing corynebacteria-associated otitis in cats than in dogs. Henneveld et al. described four cats with otitis externa/media from which corynebacteria were isolated, albeit in association with other bacterial species [7]. Two of these cats also suffered from an aural polyp.

In addition to scant information linking corynebacteria and otitis, knowledge is also limited concerning the microbiome of the healthy feline ear canal. Kose et al. investigated the flora of the normal tympanic bulla in cats but did not detect any corynebacteria, although the sample size was very small (five animals) [9].

Thus, further research is needed to elucidate the role of pathogenic bacteria in feline otitis. In this study, we present a case of feline otitis media and interna from which the recently described species Corynebacterium provencense was isolated in pure culture.

Case presentation

A 7-month-old male, neutered Maine Coon cat was presented to the Small Animal Teaching Hospital at the University of Bern with acute neurological signs consistent with unilateral otitis media/interna. Six weeks earlier an inflammatory aural polyp had been removed by traction and flushing of the ear canal. The cat had fully recovered after three weeks of treatment with oral and topical glucocorticoids and topical ofloxacin (Floxal, Bausch & Lomb Swiss AG). Otoscopic and cytologic examinations revealed brown-colored fluid in the external canal with numerous extra- and intracellular rod-shaped bacteria and neutrophils. A deep ear swab was submitted for culture and subsequent antimicrobial susceptibility testing.

The ear swab was cultured on sheep blood agar at 37 °C for 2 days, yielding a pure culture of small white colonies (strain number 17KM38). Gram staining showed Gram-positive, polymorphic rods and the bacteria were catalase positive. Thus, the bacteria were classified as belonging to the genus Corynebacterium, however species identification was not possible with either Maldi-Tof MS (MALDI Biotyper, Bruker using the in-house database and MBT 6903 MSP Library, Bruker) or VITEK® 2 Compact (Biomérieux) (cards GP and CBC). Therefore, the 16S rRNA gene was amplified and Sanger sequenced using universal primers [10]. Sequence analysis and sequence comparison using the BLAST program (NCBI, ‘rRNA_typestrains/prokaryotic_16S_ribosomal_RNA’ database) revealed 98.6% identity to Corynebacterium variabile (NR_025314.1), 98.0% to Corynebacterium terpenotabidum (NR_121699.1) and 97.8% to Corynebacterium glyciniphilum (NR_121782.1), thus the strain 17KM38 could not be assigned to any species present in the database. However, the 16S rRNA sequence showed a 100% identity with the whole genome shotgun sequence of the recently described Corynebacterium provencense SN15 (GenBank accession no.: NZ_LT160593.1) isolated from faeces of an obesity patient [11].

In order to select the appropriate antimicrobial therapy, the isolate was tested for antimicrobial resistance using broth microdilution (Sensititre EUST, Thermo Fisher Scientific) initially following in-house guidelines. Minimum inhibitory concentration (MIC) testing was however repeated according to the most recent EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines [12] using Streptococcus pneumoniae ATCC 49619 as a quality control. Briefly, the bacteria were grown on sheep blood agar at 37 °C for 24 h. They were then suspended in Mueller-Hinton broth with 5% lysed horse blood (Thermo Fisher Scientific) and 20 mg/l β-NAD to a concentration of 5 × 10⁵ CFU/ml and used for plate inoculation. Our strain tested resistant to clindamycin, penicillin and ciprofloxacin but susceptible to tetracycline, gentamicin and vancomycin. In addition, high MIC values were found for cefoxitin (8 mg/l), mupirocin (≥256 mg/l) and trimethoprim (≥32 mg/l) while the MIC for chloramphenicol was low (≤4 mg/l) (Table 1).

Table 1.

Minimal inhibitory concentrations for 17KM38, interpretation according to EUCAST clinical breakpoints where available

Antimicrobial	MIC (mg/l)	Interpretation
Clindamycin	2	R
Tetracycline	1	S
Rifampin	0.25	I
Streptomycin	≤4	–
Fusidate	1	–
Penicillin	1	R
Chloramphanicol	≤4	–
Kanamycin	≤4	–
Tiamulin	≥4	–
Quinupristin/dalfopristin	1	–
Vancomycin	≤1	S
Gentamicin	≤1	S
Trimethoprim	≥32	–
Erythromycin	≤0.25	–
Ciprofloxacin	≥8	R
Cefoxitin	8	–
Linezolid	≤1	–
Mupirocin	≥256	–
Sulfamethoxazole	≤64	–

To better characterize the strain, whole genome sequencing was performed using the PacBio method. The strain was grown on sheep blood agar at 37 °C for 24 h and the harvested cells were used to extract gDNA according to a protocol published earlier [13]. Sequencing was performed by the Lausanne Genomic Technologies Facility (University of Lausanne, Switzerland). The genome was assembled from PacBio reads using Canu 1.4 [14]. A single contig was built after assembly of the obtained reads, and circularized using amos 3.1.0 [15]. Subsequently the genome was annotated using Prokka 1.12 [16] and submitted to GenBank (Accession No. CP024988). The genome of 17KM38 has a size of 3.11 Mb and 2682 coding sequences were detected. Of these, 862 out of 2682 were annotated as hypothetical proteins. In order to confirm that 17KM38 belongs to the same species as SN15 and is indeed distinct from its closest relatives, average nucleotide identity (ANI) was calculated according to Goris et al. [17] using an online tool (ANI calculator) developed by Rodriguez-R and Konstantinidis [18] with default settings. The ANI of 17KM38 was found to be 81.5% with C. variabile (NC_015859.1), 81.0% with C. terpenotabidum (NC_021663.1), 79.1% with C. glyciniphilum (CP006842.1) and 99.1% with SN15 (FIZC01). Since the recommended cutoff point for species delineation is 95% ANI [17], these results confirm that SN15 [11] and 17KM38 indeed belong to the same species which is distinct from related species. Furthermore, a phylogenetic tree was constructed from the theoretical proteome according to Qi et al. [19] applying the online tool CVTree [20] (Fig. 1).

Fig. 1.

Phylogenetic tree based on the proteome, showing 17KM38 in relation to other corynebacteria. The tree was constructed using CVTree with K = 6. Nocardia asteroides was used as outgroup. The scale bar indicates normalized distance between composition vectors

The genome of 17KM38 was compared to the genome of the strain SN15 using mauve [21]. Gap regions were extracted and annotated resulting in 280 coding sequences (CDS), 113 of which could be assigned a putative function (Additional file 1). Interestingly, 12 CDS unique to 17KM38 are related to iron acquisition (Fig. 2), which is important for bacterial survival in the host and thus for virulence [22]. Most interesting is an approximately 17kbp region containing nine genes for siderophore synthesis and transport organized in two presumptive operons (Fig. 3) [23]. Genes dhbBCEF are related to the corresponding genes in Bacillus subtilis (between 36 and 52% identity in blastx) where they form the biosynthetic pathway for the catecholic siderophore bacillibactin [24]. The whole gene cluster has similarity to the enterobactin gene cluster in E. coli which also includes fep genes and the fes gene [25]. A gene corresponding to dhbA/entA is missing from this cluster in 17KM38, but is located elsewhere on the genome (1,026,704 - > 1,027,528). C. variabile, the closest relative to C. provencense, also possesses a repertoire of iron acquisition genes, since its habitat is the iron-restricted environment found in cheese [26]. Interestingly the genome of C. variabile also encodes a pathway similar to that for bacillibactin. However, the dhbBCEF genes in 17KM38 are no closer related to those in C. variabile than those in B. subtilis.

Fig. 2.

Comparison of 17KM38 (green) with SN15 Corynebacterium provencense (blue). CDS in gap regions are shown. Hypothetical proteins are shown in grey, proteins presumptively related to iron acquisition are shown in red. The image was constructed with BRIG (BLAST Ring Image Generator v0.95)

Fig. 3.

Comparison of the presumptive siderophore synthesis genomic region in 17KM38 and the dhb genes containing region in Bacillus subtilis (NC_000964 region: 3280000–3,293,000). The graph was generated using Easyfig 2.2.2 [23]. Comparisons were performed using tblastx, min. Length 50, max. e value 0.001

In terms of virulence factors 17KM38 encodes a candidate adhesin (Csp1_16740) related to (82% query cover, 51% identity in blastx) a cell wall-associated hydrolase of C. resistens (encoded by cwlH) [27]. The exact function of this protein is unknown, however knockout of the homologous gene DIP1621 in C. diphtheriae led to reduced adherence to epithelial cells [28]. This gene is also present in strain SN15.

As mentioned above, 17KM38 showed resistance to several antibiotics. Quinolone resistance in corynebacteria has been described to rely on mutations in the quinolone resistance determining region (QRDR) of gyrA leading to changes in the SAIYD (aa 87–91 in C. glutamicum) motif of susceptible strains [29]. Mutations of Ser-87 to Arg in C. amycolatum and to Val in C. striatum have been shown to confer quinolone resistance [29]. 17KM38 showed a mutation in this region changing Ser to Ala, which could explain the quinolone resistance. A mechanism for resistance to ß-lactams in corynebacteria has been demonstrated for C. jeikeium where acquisition of the gene pbp2C encoding the low-affinity class B penicillin binding protein 2C was shown to confer resistance [30]. 17KM38 has four genes encoding penicillin binding proteins one of which is related to pbp2C (Csp1_14570, 96% query cover, 44% identity), however, if this gene is actually related to penicillin resistance remains to be shown.

Following sensitivity testing results, the cat was treated with oral chloramphenicol palmitate solution (Cloropal, Dr. E. Gräub AG) 20 mg/kg twice daily for three weeks and an ear cleaner containing chlorhexidine digluconate (Otodine®, Ufamed AG) twice daily for two weeks. Re-examination after three weeks of therapy revealed that the head tilt was much improved and the cat was no longer ataxic and cytology of the ear canal did not show any bacteria or neutrophils.

Discussion and conclusion

Ear infections with corynebacteria in dogs and cats are rather rare; however, they are of concern to clinicians as they can be difficult to treat due to antibiotic resistance. This has also been described in human medicine where fluoroquinolones are normally used as a first-line therapy for otitis media [6]. A retrospective study by Crowson et al. found 58% of Corynebacterium sp. isolates from otitis patients were resistant to ciprofloxacin, compared to only 32% of non-Corynebacterium isolates [6]. In dogs and cats, quinolones are also frequently used to treat otitis. Aalbaek et al. found US Corynebacterium isolates from canine otitis to show a high percentage of enrofloxacin resistance when compared to Danish isolates [8]. In the case described here, the animal had also initially received topical quinolone therapy from the referring veterinarian before removal of the ear polyp. As cultures were not performed prior to this treatment, the nature of the initial infectious agent is unknown. Possibly a different bacterium caused the first infection, and the Corynebacterium provencense was able to proliferate under therapy. Alternatively, as quinolone resistance is presumably caused by a point mutation, the bacteria may have developed resistance under therapy as has been described for other species [31].

As mentioned before, not much is known about virulence factors of corynebacteria, however, iron acquisition systems are known to contribute to virulence in many pathogens [22]. Interestingly, the strain in this study contained a genomic region coding for a siderophore synthesis pathway that was not present in the human C. provencense strain and therefore might contribute to its virulence. As corynebacteria from ear infections are not routinely identified to species level in many laboratories, cases with this species may have been previously underreported. It is therefore desirable to pay more attention to corynebacterial ear infections in dogs and cats with importance placed on resistance testing as is increasingly done in human medicine. Consequently, this will improve the treatment success rate for otitis in veterinary medicine.

Abbreviations

ANI

Average Nucleotide Identity

CDS

Coding Sequence

EUCAST

European Committee on Antimicrobial Susceptibility Testing

MIC

Minimum Inhibitory Concentration

Authors’ contributions

SK performed wet lab and bioinformatics analyses and wrote the manuscript, IB performed wet lab analyses, LR contributed to bioinformatics analysis, PR provided clinical data and contributed to the manuscript, JJ and SG helped writing the manuscript. All authors read and approved the final manuscript.

Ethics approval

Written consent for the treatment of the animal and the use of anonymized data for research was obtained from the owner before sampling.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.